Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Evoq Remedies
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

EVOQ Remedies

WEBSITE BSE:543500 NSE: EVOQ Inc. Year: 2010 Industry: Trading My Bucket: Add Stock

₹3.3 -0.1 | 2.9%

Last updated: 11:14

Consolidated Standalone

Last updated: 11:14

My Notes

No Notes Added Yet

EVOQ Remedies Overview

Evoq Remedies Ltd engages inside the marketing, buying and selling, and distribution of prescription drugs raw material and chemicals in India. It trades in excipients, nutraceuticals, pellets, solvents, sweeteners, vitamins, amino acids, bulk tablets, dairy products, and active pharmaceutical components. The agency turned into integrated in 2010 and is primarily based in Ahmedabad, India.

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

EVOQ Remedies Key Financials

Market Cap ₹5 Cr.

Stock P/E 51.2

P/B 0.2

Current Price ₹3.3

Book Value ₹ 17.9

Face Value 10

52W High ₹6.1

Dividend Yield 0%

52W Low ₹ 2.3

Edit Ratio

EVOQ Remedies Share Price

₹ | |

Volume
Price

EVOQ Remedies Quarterly Price

Quarterly Monthly
Show Value Show %

EVOQ Remedies Peer Comparison

EVOQ Remedies Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

EVOQ Remedies Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 3 9 10 17 20 4 12
Other Income 0 0 0 0 6 2 2
Total Income 3 9 10 17 26 6 14
Total Expenditure 3 9 9 15 24 6 14
Operating Profit 0 0 1 1 2 1 0
Interest 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0
Profit Before Tax 0 0 1 1 2 1 0
Provision for Tax 0 0 0 0 1 0 0
Profit After Tax 0 0 1 1 2 0 0
Adjustments 0 0 0 0 0 0 0
Profit After Adjustments 0 0 1 1 2 0 0
Adjusted Earnings Per Share 0 0 10.1 0.8 1.2 0.3 0

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 200% -11% 6% 0%
Operating Profit CAGR -100% -100% 0% 0%
PAT CAGR 0% -100% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -3% -37% NA% NA%
ROE Average 0% 3% 41% 37%
ROCE Average 0% 3% 53% 48%

EVOQ Remedies Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 0 0 1 23 25 25 45
Minority's Interest 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0
Total Current Liabilities 2 6 7 10 10 12 5
Total Liabilities 2 6 8 33 35 37 50
Fixed Assets 0 0 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0 0 0
Total Current Assets 2 6 8 33 35 37 50
Total Assets 2 6 8 33 35 37 50

EVOQ Remedies Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 3 0 0
Cash Flow from Operating Activities 0 -0 0 -26 -4 5 -15
Cash Flow from Investing Activities 0 0 0 0 -0 -0 -0
Cash Flow from Financing Activities 0 0 0 29 1 -5 15
Net Cash Inflow / Outflow 0 -0 0 3 -3 -0 0
Closing Cash & Cash Equivalent 0 0 0 3 0 0 0

EVOQ Remedies Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0 0 10.08 0.8 1.19 0.33 0.04
CEPS(Rs) 0.16 0 10.08 0.8 1.19 0.34 0.06
DPS(Rs) 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0 0 10.47 17.03 18.22 18.56 17.89
Core EBITDA Margin(%) 0.5 0.01 9.52 8.72 -18.31 -40.41 -19.03
EBIT Margin(%) 0.5 0.01 9.52 8.72 11.21 15.09 1.09
Pre Tax Margin(%) 0.49 0.01 9.52 8.69 11.2 15.09 1.09
PAT Margin (%) 0.34 0 7.14 6.5 7.94 11.16 0.75
Cash Profit Margin (%) 0.34 0 7.14 6.5 7.96 11.34 1.17
ROA(%) 0.52 0.01 10.45 5.27 4.75 1.26 0.2
ROE(%) 49.78 1.34 186.89 9.13 6.75 1.81 0.25
ROCE(%) 68.94 2.69 246.9 9.12 6.96 1.92 0.35
Receivable days 137.91 119.61 210.34 350.51 381.41 853.76 160.81
Inventory Days 3.37 1.82 3.85 10.17 25.21 232.24 82.96
Payable days 239.62 156.19 288.3 105.88 6.35 321.89 94.59
PER(x) 0 0 0 28.17 10.91 26.07 72.32
Price/Book(x) 0 0 0 1.33 0.71 0.47 0.14
Dividend Yield(%) 0 0 0 0 0 0 0
EV/Net Sales(x) -0 0 -0 2.13 1.33 3.93 0.52
EV/Core EBITDA(x) -0.47 19.71 -0.02 24.47 11.83 25.7 34.78
Net Sales Growth(%) 0 179.14 10.5 67.42 21.49 -80.13 190.11
EBIT Growth(%) 0 -95.68 0 53.34 56.24 -73.25 -79.04
PAT Growth(%) 0 -97.3 0 52.53 48.38 -72.06 -80.5
EPS Growth(%) 0 0 0 -92.04 48.39 -72.07 -89.36
Debt/Equity(x) 0.05 0.27 0 0.35 0.39 0.17 0
Current Ratio(x) 1.01 1.01 1.1 3.28 3.45 3.17 9.1
Quick Ratio(x) 1 0.99 1.08 3.2 3.25 2.9 8.69
Interest Cover(x) 81 3.5 5225.15 318.04 1758.31 6115 0
Total Debt/Mcap(x) 0 0 0 0.27 0.54 0.36 0

EVOQ Remedies Shareholding Pattern

# Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Jun 2024 Sep 2024 Mar 2025 Sep 2025
Promoter 73.53 73.53 73.53 73.53 20.53 11.21 11.21 11.21 11.21
FII 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0
Public 26.47 26.47 26.47 26.47 79.47 88.79 88.79 88.79 88.79
Others 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100

EVOQ Remedies News

EVOQ Remedies Pros & Cons

Pros

  • Stock is trading at 0.2 times its book value
  • Debtor days have improved from 321.89 to 94.59days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 11.21%.
  • Company has a low return on equity of 3% over the last 3 years.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!